Postoperative Graft Volume Reduction Is Associated With Inferior Clinical Outcomes of Superior Capsule Reconstruction Using an Acellular Dermal Matrix Allograft

Clinical outcomes of arthroscopic superior capsule reconstruction in patients aged over 70 with irreparable rotator cuff tears

“…The surgical indication for most graft materials for SCR, including dermal allograft 5 , 6 and biceps long head tendon, 7 is Hamada grade 1 or 2. In the present study, excellent shoulder function was obtained after SCR using a fascia lata autograft even in Hamada grade 3 or 4, which is a specific advantage of autografting fascia lata.…”

“…Furthermore, fascia lata autograft has a higher rate of graft healing than dermal allograft. 5 , 6 Therefore, SCR using a fascia lata autograft is strongly recommended for the treatment of irreparable rotator cuff tears regardless of the patient’s age, especially when the patient requires functional improvement with pain relief.…”

“…Since we developed superior capsule reconstruction (SCR) as a joint-preserving shoulder surgery for patients with irreparable rotator cuff tears in 2007, many clinical studies have shown that SCR provides pain relief and functional improvement. 3 , 5 , 7 , 14 , 15 , 16 , 17 Biomechanical studies demonstrated that SCR improves superior glenohumeral stability by fixing the graft on both the glenoid and the greater tuberosity and restores force coupling in the glenohumeral joint by adding side-to-side suturing between the posterior rotator cuff (infraspinatus or teres minor) and the graft. 10 , 11 , 12 , 13 These biomechanical effects result in improved shoulder function and decreased shoulder pain in patients with irreparable rotator cuff tears.…”